GENERICS AND BIOSIMILARS INITIATIVE JOURNAL
Official Journal of the Generics and Biosimilars Initiative

Volume 6 / Year 2017 / Issue 1

Special Report

Patent expiry dates for biologicals: 2016 update

Author(s): GaBI Journal Editor

Page: 27-30

Abstract: Biosimilars have been approved in Europe since 2006 and in the US since 2015. With patents on originator biologicals expiring and ever-tightening healthcare budgets, biosimilars are expected to take an increasing share of the biologicals market. In light of these facts, this paper gives estimated patent expiry dates for just some of the best-selling […]

Read more →


Last update: 10/03/2017

Go Back

🖨️ Print